Electromed Company Insiders
| ELMD Stock | USD 23.15 1.26 5.16% |
Electromed employs about 177 people. The company is managed by 8 executives with a total tenure of roughly 11 years, averaging almost 1.0 years of service per executive, having 22.13 employees per reported executive. Evaluation of Electromed's management performance can provide insight into the firm performance.
| Kathleen Skarvan CEO CEO and President and Director |
Electromed | Build AI portfolio with Electromed Stock |
Electromed Management Team Effectiveness
The company has return on total asset (ROA) of 0.1362 % which means that it generated a profit of $0.1362 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.202 %, meaning that it created $0.202 on every $100 dollars invested by stockholders. Electromed's management efficiency ratios could be used to measure how well Electromed manages its routine affairs as well as how well it operates its assets and liabilities.The market capitalization of Electromed is $203.59 Million. Over half of Electromed's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Some institutional investors establish a significant position in stocks such as Electromed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Electromed, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Electromed Workforce Comparison
Electromed is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,825. Electromed holds roughly 177 in number of employees claiming about 5% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Electromed Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Electromed insiders, such as employees or executives, is commonly permitted as long as it does not rely on Electromed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Electromed insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tune Kathleen A over a month ago Acquisition by Tune Kathleen A of 3000 shares of Electromed subject to Rule 16b-3 | ||
James Cunniff over a month ago Acquisition by James Cunniff of 9000 shares of Electromed at 15.25 subject to Rule 16b-3 | ||
Kathleen Skarvan over a month ago Disposition of 40185 shares by Kathleen Skarvan of Electromed subject to Rule 16b-3 | ||
Summers Andrew over three months ago Disposition of 3153 shares by Summers Andrew of Electromed at 24.4214 subject to Rule 16b-3 | ||
Brad Nagel over three months ago Disposition of 562 shares by Brad Nagel of Electromed at 23.95 subject to Rule 16b-3 | ||
Brad Nagel over three months ago Acquisition by Brad Nagel of 9800 shares of Electromed at 23.95 subject to Rule 16b-3 | ||
James Cunniff over six months ago Insider Trading | ||
Kathleen Skarvan over six months ago Acquisition by Kathleen Skarvan of 3000 shares of Electromed subject to Rule 16b-3 |
Electromed Notable Stakeholders
An Electromed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Electromed often face trade-offs trying to please all of them. Electromed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Electromed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kathleen Skarvan | CEO and President and Director | Profile | |
| James Cunniff | Director President | Profile | |
| Amy Yanta | Quality Affairs | Profile | |
| Brad Nagel | Chief Officer | Profile | |
| Diane Kaufman | Vice Resources | Profile | |
| William George | Secretary | Profile | |
| Christopher Holland | Chief Officer | Profile | |
| Bradley Nagel | Chief Officer | Profile |
About Electromed Management Performance
The success or failure of an entity such as Electromed often depends on how effective the management is. Electromed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Electromed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Electromed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of various ages in the United States and internationally. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota. Electromed operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 156 people.
Please note, the presentation of Electromed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Electromed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Electromed's management manipulating its earnings.
Electromed Workforce Analysis
Traditionally, organizations such as Electromed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Electromed within its industry.Electromed Manpower Efficiency
Return on Electromed Manpower
| Revenue Per Employee | 361.6K | |
| Revenue Per Executive | 8M | |
| Net Income Per Employee | 42.6K | |
| Net Income Per Executive | 942.1K | |
| Working Capital Per Employee | 195.6K | |
| Working Capital Per Executive | 4.3M |
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |